This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses may be missing. Find their university profile.
Research
Latest papers
The deubiquitinase USP17 regulates the expression and activity of the oncogenic driver β-catenin in colorectal cancer.
Oncogene · 2026
A spatial map of MAPK-activated immunosuppressive myeloid populations in pediatric low-grade glioma.
Nature immunology · 2025
KRAS ctDNA Detection in Patients With Resectable Lung Adenocarcinoma.
Clinical lung cancer · 2025
Latest funding
- $1,109,250
Combining highly multiplexed imaging data with AI to unlock new predictive biomarkers for lung cancer
CIHR · 2024 · Nominated PI
- $1,109,250
Enhancing immunotherapy through the food-gut-axis in non-small cell lung cancer
CIHR · 2023 · Nominated PI
- $250,000
MULTI -TUMOUR BASED PREDICTION AND MANIPULATION OF IMMUNE RESPONSE
SSHRC · 2022 · Principal investigator
5 publications.
The deubiquitinase USP17 regulates the expression and activity of the oncogenic driver β-catenin in colorectal cancer.
Acevedo M, Dô F, El-Mortada F, Tanguay PL, Voisin L, Houles T, Lavoie G, Allard D, Roux PP, Stagg J, Doré S, Walsh L, Fourtounis J, Bonneil E, Meloche S, Servant MJ
A spatial map of MAPK-activated immunosuppressive myeloid populations in pediatric low-grade glioma.
Andrade AF, Sigaud R, Puligandla E, Liu B, Karimi E, Annett A, Rezanejad M, Jawhar W, Taylor R, Cao Y, Schmid S, Selt F, Hernáiz Driever P, Horn S, Sievers P, Prinz M, Glatzel M, Mawrin C, Hartmann C, Monoranu CM, Konnikova L, Sahm F, Pfister SM, Witt O, Jones DTW, Koch A, Kleinman CL, Capper D, Walsh L, Jabado N, Milde T
KRAS ctDNA Detection in Patients With Resectable Lung Adenocarcinoma.
De Meo ML, Seitlinger J, Rayes RF, Walsh LC, Shahzad MH, Tsering T, Saleh R, Ezer N, Shieh B, Wong A, Owen S, Walsh L, Fiset PO, Burnier JV, Spicer JD
Chemosensor receptors are lipid-detecting regulators of macrophage function in cancer.
Marelli G, Morina N, Puccio S, Iovino M, Pandini M, Portale F, Carvetta M, Mishra D, Diana E, Meregalli G, Paraboschi E, Cibella J, Peano C, Basso G, De Simone G, Camisaschi C, Magrini E, Sartori G, Karimi E, Colombo P, Lazzeri M, Casale P, Morosi L, Martano G, Asselta R, Bonavita E, Matsunami H, Bertoni F, Walsh L, Lugli E, Di Mitri D
Primary tumors induce neutrophil extracellular traps with targetable metastasis promoting effects.
Rayes RF, Mouhanna JG, Nicolau I, Bourdeau F, Giannias B, Rousseau S, Quail D, Walsh L, Sangwan V, Bertos N, Cools-Lartigue J, Ferri LE, Spicer JD
Combining highly multiplexed imaging data with AI to unlock new predictive biomarkers for lung cancer
Principal investigators: Walsh, Logan A
Keywords: Biomarkers; Imaging Mass Cytometry; Immunotherapy; Lung Cancer; Mouse Models
Enhancing immunotherapy through the food-gut-axis in non-small cell lung cancer
Principal investigators: Walsh, Logan A
Keywords: Biomarkers; Lung Cancer; Microbiome; Microenvironment; Mouse Models; Obesity
MULTI -TUMOUR BASED PREDICTION AND MANIPULATION OF IMMUNE RESPONSE
Principal investigators: Walsh, Logan
Keywords: Cancer; immunotherapy; biomarkers; imaging mass cytometry; artificial intelligence
Diet and obesity influence immune checkpoint inhibitor efficacy in lung cancer
Principal investigators: Desharnais, Lysanne
Keywords: Diet; Gut Microbiome; Immune Checkpoint Inhibitor; Inflammation; Obesity; Oncology
Deciphering the role of the immune microenvironment in the response of lung cancer to immunotherapy
Principal investigators: Joubert, Philippe
uPA: a novel actionable target for patients with lung squamous cell carcinomas.
Principal investigators: Fiore, Amanda
Keywords: Biomarker; Chemotherapy; Immunotherapy Adjuvant; Lung Cancer Subtyping; Non-Small Cell Lung Carcinoma; Personalized Medicine; Preclinical Lung Cancer Models; Squamous Cell Carcinoma Of The Lung; Urokinase; Urokinase-Type Plasminogen Activator
Drivers of breast cancer progression identified within arm-level somatic copy number alterations
Principal investigators: Walsh, Logan A
Keywords: Breast Cancer; Genetics; Genomics; Metastasis; Molecular Biology
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Nada Jabado and Pierre-Olivier Fiset: 2 shared papers
- Nicole Ezer and Pierre-Olivier Fiset: 2 shared papers
- Pierre-Olivier Fiset and Ramy Saleh: 2 shared papers
- Simon Rousseau and Daniela Quail: 1 shared paper
- Simon Rousseau and Logan Walsh: 1 shared paper
- Nada Jabado and Logan Walsh: 1 shared paper
- Sylvain Meloche and Logan Walsh: 1 shared paper
- Daniela Quail and Logan Walsh: 1 shared paper
- Logan Walsh and Nicole Ezer: 1 shared paper
- Logan Walsh and Pierre-Olivier Fiset: 1 shared paper
- Logan Walsh and Ramy Saleh: 1 shared paper
- Nicole Ezer and Ramy Saleh: 1 shared paper
- Human Genetics
- Physiology
- Pediatrics
- Respirology
- Medicine
- Institut de recherche en immunologie et cancer
- Other
Co-authors at McGill University, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Nicole Ezer
Respirology
1 shared papers, latest 2025
Pierre-Olivier Fiset
Faculty
1 shared papers, latest 2025
Ramy Saleh
Medicine
1 shared papers, latest 2025
Simon Rousseau
Faculty
1 shared papers, latest 2019
Nada Jabado
Pediatrics
1 shared papers, latest 2025
Sylvain Meloche
Institut de recherche en immunologie et cancer
1 shared papers, latest 2026
Daniela Quail
Physiology
1 shared papers, latest 2019
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.